AbbVie (ABBV) Short Interest Ratio & Short Volume

$189.93

-0.47 (-0.25%)

(As of 08/9/2024 ET)

AbbVie Short Interest Data

AbbVie (ABBV) has a short interest of 16.38 million shares, representing 0.93% of the float (the number of shares available for trading by the public). This marks a 0.99% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 5.58 million shares to cover all short positions.

Current Short Interest: 16,380,000 shares
Previous Short Interest: 16,220,000 shares
Change Vs. Previous Month: +0.99%
Dollar Volume Sold Short: $2.75 billion
Short Interest Ratio: 3.0 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 1,765,868,000 shares
Float Size: 1,760,000,000 shares
Short Percent of Float: 0.93%
Today's Trading Volume: 3,201,859 shares
Average Trading Volume: 5,580,519 shares
Today's Volume Vs. Average: 57%

Short Selling AbbVie?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

Ad Stansberry Research

Wall St Legend: Rate Cuts Can't Stop What's Next

As recession fears grow and markets plunge... Experts are clamoring for emergency rate cuts to stop the hemorrhage. But according to a former hedge fund manager who's been through five rate cut cycles... No amount of rate cuts can stop the huge shift that's about to take hold of the markets.

Don't get caught off-guard – click here now to prepare for what's coming.

AbbVie Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	16,380,000 shares	$2.75 billion	+1.0%	0.9%	3	$168.03
6/30/2024	16,220,000 shares	$2.78 billion	+6.4%	0.9%	3	$171.52
6/15/2024	15,250,000 shares	$2.57 billion	-7.5%	0.9%	2.9	$168.59
5/31/2024	16,490,000 shares	$2.66 billion	+3.5%	0.9%	2.9	$161.19
5/15/2024	15,930,000 shares	$2.61 billion	+10.0%	0.9%	2.9	$163.78
4/30/2024	14,480,000 shares	$2.36 billion	+6.9%	0.8%	2.6	$162.69
Get the Latest News and Ratings for ABBV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	13,540,000 shares	$2.19 billion	+3.2%	N/A	2.4	$161.67
3/31/2024	13,120,000 shares	$2.39 billion	-10.7%	N/A	2.3	$182.10
3/15/2024	14,690,000 shares	$2.61 billion	+2.9%	0.8%	2.7	$177.88
2/29/2024	14,270,000 shares	$2.51 billion	-3.3%	0.8%	2.6	$175.61
2/15/2024	14,750,000 shares	$2.60 billion	+7.5%	0.8%	2.8	$176.61
1/31/2024	13,720,000 shares	$2.26 billion	+1.2%	0.8%	2.5	$164.36
1/15/2024	13,560,000 shares	$2.20 billion	+12.3%	0.8%	2.4	$162.40
12/31/2023	12,080,000 shares	$1.87 billion	-11.8%	0.7%	2.2	$154.97
12/15/2023	13,690,000 shares	$2.11 billion	+23.0%	0.8%	2.6	$154.07
11/30/2023	11,130,000 shares	$1.58 billion	-0.2%	0.6%	2.2	$142.35
11/15/2023	11,150,000 shares	$1.53 billion	-15.7%	0.6%	2.4	$137.61
10/31/2023	13,230,000 shares	$1.87 billion	+15.3%	0.8%	3	$141.18
10/15/2023	11,470,000 shares	$1.70 billion	-6.8%	0.7%	2.6	$147.96
9/30/2023	12,310,000 shares	$1.83 billion	+3.2%	0.7%	2.7	$149.06
9/15/2023	11,930,000 shares	$1.81 billion	-4.2%	0.7%	2.4	$152.09
8/31/2023	12,450,000 shares	$1.83 billion	-6.1%	0.7%	2.4	$146.96
8/15/2023	13,260,000 shares	$2.02 billion	+15.9%	0.8%	2.3	$152.12
7/31/2023	11,440,000 shares	$1.71 billion	+20.3%	0.7%	2	$149.58
7/15/2023	9,510,000 shares	$1.29 billion	-8.2%	0.5%	1.6	$136.01
6/30/2023	10,360,000 shares	$1.40 billion	-8.4%	0.6%	1.8	$134.72
6/15/2023	11,310,000 shares	$1.54 billion	-0.6%	0.6%	2	$135.89
5/31/2023	11,380,000 shares	$1.57 billion	-4.9%	0.7%	1.9	$137.96
5/15/2023	11,970,000 shares	$1.75 billion	-23.5%	0.7%	2.1	$146.59
4/30/2023	15,650,000 shares	$2.37 billion	+3.4%	0.9%	2.6	$151.12
4/15/2023	15,140,000 shares	$2.45 billion	-7.0%	N/A	2.6	$161.59
3/31/2023	16,280,000 shares	$2.59 billion	+16.0%	N/A	2.6	$159.37
3/15/2023	14,040,000 shares	$2.16 billion	+10.6%	N/A	2.3	$154.06
2/28/2023	12,700,000 shares	$1.95 billion	+8.5%	N/A	2.3	$153.90
2/15/2023	11,710,000 shares	$1.77 billion	+13.7%	N/A	2.1	$151.06
1/31/2023	10,300,000 shares	$1.52 billion	-13.9%	N/A	1.8	$147.75
1/15/2023	11,960,000 shares	$1.84 billion	-7.5%	N/A	2.2	$153.60
12/30/2022	12,930,000 shares	$2.09 billion	-4.8%	N/A	2.5	$161.61
12/15/2022	13,580,000 shares	$2.21 billion	-0.6%	N/A	2.4	$163.10
11/30/2022	13,660,000 shares	$2.20 billion	+5.8%	N/A	2.4	$161.18
Wall St Legend: Rate Cuts Can't Stop What's Next (Ad) As recession fears grow and markets plunge... Experts are clamoring for emergency rate cuts to stop the hemorrhage. But according to a former hedge fund manager who's been through five rate cut cycles... No amount of rate cuts can stop the huge shift that's about to take hold of the markets. Don't get caught off-guard – click here now to prepare for what's coming.
11/15/2022	12,910,000 shares	$1.98 billion	-6.5%	N/A	2.3	$153.04
10/31/2022	13,800,000 shares	$2.02 billion	-1.4%	N/A	2.6	$146.40
10/15/2022	14,000,000 shares	$2.00 billion	+5.3%	N/A	2.6	$142.94
9/30/2022	13,290,000 shares	$1.78 billion	+2.6%	N/A	2.4	$134.21
9/15/2022	12,950,000 shares	$1.85 billion	+13.8%	N/A	2.4	$142.51
8/31/2022	11,380,000 shares	$1.53 billion	-12.5%	N/A	2.1	$134.46
8/15/2022	13,010,000 shares	$1.85 billion	-6.1%	N/A	2.2	$142.29
7/31/2022	13,850,000 shares	$1.99 billion	-1.3%	0.8%	2.2	$143.51
7/15/2022	14,030,000 shares	$2.16 billion	-2.7%	0.8%	2.1	$153.62
6/30/2022	14,420,000 shares	$2.21 billion	+6.7%	1.0%	2	$153.16
6/15/2022	13,520,000 shares	$1.87 billion	+6.0%	0.9%	1.9	$138.09
5/31/2022	12,750,000 shares	$1.88 billion	-10.4%	0.7%	1.8	$147.37
5/15/2022	14,230,000 shares	$2.18 billion	+8.2%	0.8%	1.9	$153.50
4/30/2022	13,150,000 shares	$1.93 billion	+9.0%	0.8%	1.7	$146.88
4/15/2022	12,070,000 shares	$1.96 billion	-10.2%	0.7%	1.5	$162.31
3/31/2022	13,440,000 shares	$2.18 billion	-9.7%	0.8%	1.7	$162.11
3/15/2022	14,890,000 shares	$2.32 billion	-6.9%	N/A	1.9	$155.88
2/28/2022	15,990,000 shares	$2.36 billion	+3.9%	N/A	2	$147.77
2/15/2022	15,390,000 shares	$2.23 billion	-4.7%	N/A	2	$144.76
1/31/2022	16,150,000 shares	$2.21 billion	+12.7%	0.9%	2.3	$136.89
1/15/2022	14,330,000 shares	$1.95 billion	-13.7%	0.8%	2.2	$135.87
12/31/2021	16,610,000 shares	$2.25 billion	+7.6%	0.9%	2.7	$135.40
12/15/2021	15,440,000 shares	$2.01 billion	+9.4%	0.9%	2.5	$130.23
11/30/2021	14,120,000 shares	$1.63 billion	+0.2%	N/A	2.3	$115.28
11/15/2021	14,090,000 shares	$1.65 billion	+3.5%	0.8%	2	$116.84
10/29/2021	13,620,000 shares	$1.56 billion	+18.5%	0.8%	1.9	$114.67
10/15/2021	11,490,000 shares	$1.26 billion	-16.0%	0.7%	1.6	$109.33
9/30/2021	13,670,000 shares	$1.47 billion	+5.2%	0.8%	1.9	$107.87
9/15/2021	12,990,000 shares	$1.40 billion	-4.1%	0.7%	1.9	$107.77
8/31/2021	13,550,000 shares	$1.64 billion	+3.5%	0.8%	2	$120.78
8/13/2021	13,090,000 shares	$1.52 billion	-9.4%	0.7%	2.2	$116.48
7/30/2021	14,450,000 shares	$1.68 billion	-1.4%	0.8%	2.3	$116.30
7/15/2021	14,660,000 shares	$1.72 billion	+6.5%	0.8%	2.3	$117.18
6/30/2021	13,770,000 shares	$1.55 billion	+3.2%	0.8%	2.2	$112.64
6/15/2021	13,340,000 shares	$1.55 billion	-9.6%	0.8%	2	$115.83
5/28/2021	14,760,000 shares	$1.67 billion	-3.4%	0.8%	2.1	$113.20
5/14/2021	15,280,000 shares	$1.78 billion	+2.6%	N/A	2.2	$116.60
4/30/2021	14,890,000 shares	$1.65 billion	-20.4%	N/A	2.2	$110.89
4/15/2021	18,710,000 shares	$1.98 billion	+11.4%	N/A	2.6	$105.90
3/31/2021	16,800,000 shares	$1.79 billion	+3.7%	N/A	2.3	$106.79
3/15/2021	16,200,000 shares	$1.75 billion	+5.0%	N/A	2.2	$108.22
2/26/2021	15,430,000 shares	$1.66 billion	+8.1%	N/A	2.2	$107.33
2/12/2021	14,280,000 shares	$1.48 billion	-4.0%	N/A	1.9	$103.75
1/29/2021	14,870,000 shares	$1.55 billion	+18.1%	N/A	1.9	$104.21
1/15/2021	12,590,000 shares	$1.41 billion	-5.6%	N/A	1.5	$111.63
12/31/2020	13,330,000 shares	$1.40 billion	-3.8%	N/A	1.6	$105.27
12/15/2020	13,850,000 shares	$1.44 billion	+4.4%	N/A	1.7	$104.20
11/30/2020	13,270,000 shares	$1.39 billion	-5.2%	N/A	1.6	$104.89
11/15/2020	14,000,000 shares	$1.39 billion	+9.0%	N/A	1.7	$99.04
10/30/2020	12,840,000 shares	$1.04 billion	+20.7%	N/A	1.6	$80.67
Wall St Legend: Rate Cuts Can't Stop What's Next (Ad) As recession fears grow and markets plunge... Experts are clamoring for emergency rate cuts to stop the hemorrhage. But according to a former hedge fund manager who's been through five rate cut cycles... No amount of rate cuts can stop the huge shift that's about to take hold of the markets. Don't get caught off-guard – click here now to prepare for what's coming.
10/15/2020	10,640,000 shares	$915.78 million	-17.8%	N/A	1.5	$86.07
9/30/2020	12,940,000 shares	$1.13 billion	-2.6%	N/A	1.9	$87.59
9/15/2020	13,280,000 shares	$1.21 billion	+9.2%	N/A	1.9	$90.91
8/31/2020	12,160,000 shares	$1.16 billion	-2.0%	N/A	1.7	$95.77
8/14/2020	12,410,000 shares	$1.18 billion	-6.3%	N/A	1.7	$95.07
7/31/2020	13,240,000 shares	$1.26 billion	-3.2%	N/A	1.5	$94.91
7/15/2020	13,680,000 shares	$1.37 billion	-15.6%	N/A	1.4	$100.48
6/30/2020	16,210,000 shares	$1.59 billion	-18.0%	N/A	1.6	$98.18
6/15/2020	19,760,000 shares	$1.84 billion	+2.9%	N/A	1.8	$93.08
5/29/2020	19,200,000 shares	$1.78 billion	-22.6%	N/A	1.5	$92.67
5/15/2020	24,800,000 shares	$2.25 billion	-70.9%	N/A	1.8	$90.71
4/30/2020	85,240,000 shares	$7.01 billion	+0.6%	5.8%	6.6	$82.20
4/15/2020	84,730,000 shares	$6.93 billion	+0.1%	5.8%	6.8	$81.82
3/31/2020	84,640,000 shares	$7.08 billion	+3.7%	5.8%	6.8	$83.59
3/13/2020	81,623,800 shares	$6.51 billion	+5.0%	5.5%	8.8	$79.75
2/28/2020	77,760,000 shares	$5.02 billion	-1.6%	N/A	8.4	$64.50
2/14/2020	79,020,000 shares	$6.92 billion	+5.7%	N/A	9.4	$87.53
1/31/2020	74,740,000 shares	$6.61 billion	-2.5%	N/A	9	$88.41
1/15/2020	76,680,000 shares	$7.36 billion	+6.6%	N/A	9.9	$96.00
12/31/2019	71,950,000 shares	$6.01 billion	+4.5%	N/A	9.9	$83.54

ABBV Short Interest - Frequently Asked Questions

What is AbbVie's current short interest?: Short interest is the volume of AbbVie shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 16,380,000 shares of ABBV short. 0.93% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest.
What is a good short interest ratio for AbbVie?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 3.0. Learn More on AbbVie's short interest ratio.
Which institutional investors are shorting AbbVie?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Delta Accumulation LLC, Delta Accumulation LLC, National Bank of Canada FI, Wolverine Asset Management LLC, Bender Robert & Associates, Concourse Financial Group Securities Inc., Portman Square Capital LLP, Gladius Capital Management LP, SteelPeak Wealth LLC, Wealth Enhancement Advisory Services LLC, NorthCrest Asset Manangement LLC, IMC Chicago LLC, SG Americas Securities LLC, Walleye Trading LLC, Jane Street Group LLC, BlueCrest Capital Management Ltd, and PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
What is a good short interest percentage for AbbVie?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.93% of AbbVie's floating shares are currently sold short.
Is AbbVie's short interest increasing or decreasing?: AbbVie saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 16,380,000 shares, an increase of 1.0% from the previous total of 16,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is AbbVie's float size?: AbbVie currently has issued a total of 1,765,868,000 shares. Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbbVie currently has a public float of 1,760,000,000 shares.

How does AbbVie's short interest compare to its competitors?: 0.93% of AbbVie's shares are currently sold short. Here is how the short interest of companies compare to AbbVie: Amgen Inc. (1.79%), Gilead Sciences, Inc. (1.71%), IQVIA Holdings Inc. (1.48%), IDEXX Laboratories, Inc. (3.27%), Moderna, Inc. (6.75%), BioNTech SE (1.42%), Illumina, Inc. (3.00%), Eli Lilly and Company (0.74%), Johnson & Johnson (0.75%), Merck & Co., Inc. (0.97%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short AbbVie stock?: Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading down $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against AbbVie?: A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.
How often is AbbVie's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is July, 15 2024.